| Literature DB >> 25519761 |
Tung-Yi Lin, Tsung-Ting Tsai1, Meng-Ling Lu, Chi-Chien Niu, Ming-Kai Hsieh, Tsai-Sheng Fu, Po-Liang Lai, Lih-Huei Chen, Wen-Jer Chen.
Abstract
BACKGROUND: Percutaneous pedicle screw instrumentation is a minimally invasive surgical technique; however, the effects of using percutaneous pedicle screw fixation in treating patients with spinal infections have not yet been well demonstrated. The aim of this study, therefore, was to determine whether percutaneous posterior pedicle screw instrumentation is superior to the traditional open approach in treating pyogenic spondylodiscitis.Entities:
Mesh:
Year: 2014 PMID: 25519761 PMCID: PMC4300775 DOI: 10.1186/1471-2474-15-443
Source DB: PubMed Journal: BMC Musculoskelet Disord ISSN: 1471-2474 Impact factor: 2.362
Figure 1A case of hematogenous pyogenic spondylodiscitis. ( A) Coronal plane of lumbar spine MRI and (B) sagittal view revealed infectious spondylodiscitis at L2-3. (C) Postoperative lateral radiograph demonstrated the presence of cortical allograft and percutaneous posterior instrumentation.
Figure 2A case of hematogenous pyogenic spinal infection . (A) Preoperative lateral radiograph showed obvious disc space narrowing with endplate erosion at L4-5, and focal kyphosis (B) MRI revealed L4-5 infectious spondylodiscitis. (C) Postoperative lateral radiograph demonstrated the presence of anterior interbody fusion with allograft and percutaneous posterior pedicle screw. (D) Postoperative lateral view at two-year follow-up revealed bone union without progression in focal kyphosis.
Figure 3A case of hematogenous pyogenic spinal infections. ( A) Preoperative lateral radiograph showed disc space narrowing with endplate erosion at L3-4 level, and (B) MRI revealed L3-4 spondylodiscitis. (C) Postoperative lateral radiograph demonstrated the presence of anterior interbody fusion with allograft and traditional open posterior pedicle screw. (D) Postoperative lateral view at two-year follow-up revealed union of L3-4 interbody fusion.
Comparison of data between the percutaneous and open groups
| Percutaneous group (n = 20) | Open group (n = 25) |
| |
|---|---|---|---|
| Age (yr) | 59.6 | 64.7 | 0.113 |
| Sex | 14 males | 11 males | 0.085 |
| 6 females | 14 females | ||
| Anterior operative time (min) | 149 ± 39.5 | 156 ± 33.7 | 0.534 |
| Anterior blood loss (mL) | 577.5 ± 203.4 | 594 ± 194.1 | 0.788 |
| Posterior operative time (min) | 102.5 ± 28.3 | 129 ± 20.9 | 0.001* |
| Posterior blood loss (mL) | 89 ± 34.6 | 344.8 ± 155.2 | <0.001* |
| Number of analgesic injections | 3.9 ± 2.1 | 5 ± 1.4 | 0.042* |
| VAS score, next day after posterior instrumentation | 4 ± 1.3 | 5.5 ± 1.2 | <0.001* |
| VAS score, 7 days after posterior instrumentation | 2.8 ± 1.2 | 3.5 ± 0.9 | 0.03* |
VAS, visual analogue scale.
Data presented as mean ± standard deviation, and *P < 0.05.
Causative organisms
| Organisms | Percutaneous group (n = 20) | Open group (n = 25) |
|---|---|---|
| MSSA | 5(25%) | 6 (24%) |
| MRSA | 3(15%) | 4 (16%) |
| Staph.epidermidis | 2(10%) | 2 (8%) |
| E. coli | 0 | 3 (12%) |
| Pseudo.aeruginosa | 2(10%) | 1 (4%) |
| Enterococcus faecalis | 0 | 1 (4%) |
| Kleb. Pneumoniae | 4(20%) | 2 (8%) |
| Penicillium species | 0 | 2 (8%) |
| Streptococcus Group B | 1(5%) | 0 |
| Culture negative | 3(15%) | 4 (16%) |
MRSA = Methicillin-resistant Staphylococcus aureus, MSSA = Methicillin-sensitive Staphylococcus aureus.
Patient comorbidity and perioperative complications
| Percutaneous group (n = 20) | Open group (n = 25) | |
|---|---|---|
| Patient comorbidity | ||
| Hypertension | 7(35%) | 12(48%) |
| Diabetes mellitus | 9(45%) | 13(52%) |
| Liver cirrhosis | 2(10%) | 2(8%) |
| End stage renal disease | 3(15%) | 3(12%) |
| Cancer history | 2(10%) | 2(8%) |
| COPD | 1(5%) | 1(4%) |
| Perioperative complications | ||
| Incidental durotomy | 0 | 0 |
| Wound problem | 1 | 2 |
| Donor site infection | 0 | 0 |
| Pneumonia | 0 | 0 |
| Urinary tract infection | 0 | 0 |
| Screw malposition | 0 | 2 |
COPD = Chronic obstructive pulmonary disease.